Stock VIRX VIRACTA THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Viracta Therapeutics, Inc.

Equities

VIRX

US92765F1084

Delayed Nasdaq
Other stock markets
 19:35:01 29/04/2024 BST 		5-day change 1st Jan Change
0.8499 USD +2.61% Intraday chart for Viracta Therapeutics, Inc. -3.42% +49.11%
04-15 Viracta Therapeutics, Inc. Reports Positive Topline Results from Stage 1 of the Pivotal Phase 2 NAVAL-1 Trial CI
04-01 Viracta Therapeutics to Present Topline Nana-val Results from Stage 1 of the NAVAL-1 Trial at the 2024 Annual Congress of The Hematology Society of Taiwan CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
RBC Cuts Price Target on Viracta Therapeutics to $6 From $7, Keeps Outperform, Speculative Risk
MT
HC Wainwright Lowers Price Target on Viracta Therapeutics to $10 From $33, Maintains Buy Rating
MT
RBC Cuts Price Target on Viracta Therapeutics to $7 From $8, Maintains Outperform, Speculative Risk Rating
MT
Oppenheimer Adjusts Viracta Therapeutics Price Target to $16 From $14, Maintains Outperform Rating
MT
RBC Cuts Price Target on Viracta Therapeutics to $8 From $10, Maintains Outperform, Speculative Risk
MT
History shows stocks can weather rate hike cycle
RE
Viracta Therapeutics Initiated at Outperform by RBC With Speculative Risk Qualifier, Price Target Started at $10/Share
MT
Viracta Says Epstein-Barr Therapy Had 40% Overall Response Rate in Trial; Shares Fall
MT
VIRACTA THERAPEUTICS : HC Wainwright Starts Viracta Therapeutics at Buy With $35 Price Target
MT
VIRACTA THERAPEUTICS : SVB Leerink Initiates Viracta Therapeutics at Outperform With $18 Price Target
MT
VIRACTA THERAPEUTICS : Evercore ISI Starts Viracta Therapeutics at Outperform with $45 Price Target
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. VIRX Stock
  4. News Viracta Therapeutics, Inc.
  5. Analyst Reco.